What the research examined
A rat study investigated GHRP-6 in a doxorubicin-associated injury model. Researchers examined cardiac function, tissue structure, oxidative-stress measurements, and cell-survival markers. The experimental observations concern a defined drug-induced injury setting.
How to interpret the findings
This is preclinical evidence. Results do not establish a clinical protective effect, and an induced injury model does not capture the full complexity of disease or exposure in people.
Research literature
- Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms.
Frontiers in pharmacology · 2024 · PMID 38873418
Links open the indexed paper records. Summaries are based on those records and their available abstracts, not a systematic review or a full-text appraisal of every study.